Perceptive Life Sciences
Venture capital · Manhattan, New York, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
5Deep-tech portfolio1 active
4Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Relay Therapeutics
68Co-investorsShare a portfolio company
Portfolio · 5 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Prelude Therapeutics | Biotech | Active | Aug 28, 2020 | $97.0M |
| Relay Therapeutics | Biotech | Public | Jan 10, 2024 | $30.0M |
| Nuvation Bio | Biotech | Public | Oct 20, 2020 | $275.3M |
| Passage Bio | Biotech | Public | Sep 6, 2019 | $110.0M |
| Day One Biopharmaceuticals | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#81
Portfolio exits#49
Raises, 12 months#88
Co-investors#14
Co-investors
- Boxer CapitalVenture capital5 shared
- Deerfield Capital ManagementVenture capital4 shared
- Perceptive AdvisorsVenture capital4 shared
- Frazier Healthcare PartnersVenture capital3 shared
- GVVenture capital3 shared
- Third Rock VenturesVenture capital3 shared
- Apple Tree PartnersVenture capital2 shared
- Ascent Biomedical VenturesVenture capital2 shared
- Bay City CapitalVenture capital2 shared
- BioAdvanceVenture capital2 shared
Sectors
- Biotech5
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.